Table 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.



Similar documents
STARCH Application Data

Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms

High Performance Dry Binding with CELNY-SSL Super Fine Powder

QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

High Performance Dry Binding with HPC-SSL Super Fine Powder

It is an important tool to assess factors that affect the bioavailability of a drug from a solid preparartion.

TABLET REFORMULATION CASE STUDY. Executive Summary

FORMULATION EVALUATION AND OPTIMIZATION OF AN ORAL IMMEDIATE RELEASE ANTIBIOTIC FORMULATION OF AMOXICILLINE

Journal of Chemical and Pharmaceutical Research

POLYOX. Application Data

Formulation and Evaluation of Didanosine Enteric Coated Sustained Release Tablet

Effect of Filler Type on the Stability of Polyethylene Oxide in a Hydrophilic Matrix Tablet

Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release

The importance of normalisation when comparing tablet properties

Research Article Prospective Validation of Paracetamol Tablet Dosage Form

Quality by Design for ANDAs: An Example for Modified Release Dosage Forms

Solid dosage forms testing: Disintegration test and tablet friability and hardness

The Story of Magnesium Stearate as a Powder and a Tablet Lubricant

THE PHARMACEUTICAL INDUSTRY

POLYOX. Application Data. Formulation of POLYOX ER Matrices for a Highly Soluble Active APPLICATIONS DATA SUMMARY INTRODUCTION POLYOX - 1 -

CHARACTERIZATION AND EVALUATION OF OKRA GUM AS A TABLET BINDER

Process Validation Protocol (Reference: SOP )

PREPARATION AND EVALUATION OF STARCH PHOSPHATE- A NEW MODIFIED STARCH AS A DISINTEGRANT IN TABLET FORMULATIONS

Formulation and evaluation of enteric coated tablet of Ilaprazole

FORMULATION DEVELOPMENT AND EVALUAVATION OF AMOXICILLIN TRIHYDRATE AND POTASSIUM CLAVULANATE IMMEDIATE RELEASE TABLETS

Generic Drug Formulations. with. and. Kollidon SR

Generic drugs are copies of innovator drug products

PRODUCT DEVELOPMENT GUIDE

2.3 QUALITY OVERALL SUMMARY Sakura Tablet

IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION

Formulation and Evaluation of Immediate Release Bilayer Tablets of Telmisartan and Hydrochlorothiazide

PROCESS VALIDATION OF TABLETS: AN OVERVIEW

Comparative Assessment of the Quality Control Measurements of Multisource Ofloxacin Tablets Marketed in Nigeria

Guidance for Industry

EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (43) Date of publication: Bulletin 2011/15

Dissolution Rate Enhancement of Fenofibrate Using Liquisolid Tablet Technique. Part II: Evaluation of In Vitro Dissolution Profile Comparison Methods.

Pharmaceutical Quality Systems: US Perspective

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Tablets and Capsules: Design and Formulation

Vinod et al., ARPB, 2013; Vol 3 (II) ISSN

GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES

All the prepared formulations were subjected for following. evaluation parameters and obtained results were showed in Tables 6.3 &

EUDRAGIT E 100, EUDRAGIT E PO and

Vol. 4, Issue 3, 2011 ISSN FORMULATION AND EVALUATION OF ESOMEPRAZOLE DELAYED RELEASE TABLETS TUSHAR G. RUKARI 1 *, GANESH V.

Sample preparation for X-ray fluorescence analysis

Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA

Influence of the Changed USP Specifications on Disintegration Test Performance

FAO SPECIFICATIONS FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

AMBERLITE IRP64 Pharmaceutical Grade Cation Exchange Resin (Polacrilex Resin)

The identification of tablets and capsules containing barbiturates by MATR infrared spectroscopy

Process Systems Engineering in Pharmaceutical Development & Manufacture

Research Article FORMULATION AND EVALUATION OF FAST DISINTEGRATING LOSARTAN POTASSIUM TABLETS BY FORMAL EXPERIMENTAL DESIGN

Department of Materials Science and Metallurgy, University of Cambridge, CB2 3QZ,UK

RESEARCH ARTICLE PREPARATION AND EVALUATION OF LEVOFLOXACIN HEMIHYDRATES FLOATING TABLETS

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES Formulation and evaluation of intragastric buoyant tablets of amoxicillin trihydrate

FEED MANUFACTURING TECHNOLOGY - ISSUES AND CHALLENGES

Asian Journal of Research in Biological and Pharmaceutical Sciences Journal home page:

EFFECT OF DIFFERENT BIOADHESIVE POLYMERS ON PERFORMANCE CHARACTERISTICS OF VAGINAL TABLETS

Palasurance SPDD Granulated Enhances Palatability and Tableting Performance in Companion Animal Supplements Technical Services

Andries F. Marais 1, Mingna Song 2 and Melgardt M. de Villiers 2Φ 1. Research Article. Marais et al. Abstract

The Director Software V4 and the Scalability Tool

Prescription drug products stability and expiration dates*

SCHEDULE No. 1: Oral solid dosage forms: Fluoroquinolones

AMBERLITE IRP69 Pharmaceutical Grade Cation Exchange Resin (Sodium Polystyrene Sulfonate USP)

ETHYL LAUROYL ARGINATE

Control Strategy Case Studies

Tablets UNIT III V.MANIMARAN LECTURER DEPARTMENT OF PHARMACEUTICS SRM COLLEGE OF PHARMACY

USP Certificate PREDNISONE TABLETS. USP Catalog No.: USP Lot No.: R031Y0 (10 mg nominal prednisone content per tablet)

POWDER PROPERTIES LABORATORY

ICH Topic Q4B Annex 5 Disintegration Test General Chapter. Step 3

FOR PLANT PROTECTION PRODUCTS FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS

Top and Bottom Spray Fluid Bed Granulation Process

International Research Journal of Pharmaceutical and Applied Sciences Available online at Int. Res J Pharm. App Sci.

International Journal of Applied Pharmaceutics Vol 2, Issue 3, 2010

Copolymer 845, 845-O & Copolymer 937 polymers Versatile Fixative Polymers for Styling Gels and Mousses

DEVELOPMENT AND CHARACTERIZATION OF MELT-IN-MOUTH TABLETS OF HALOPERIDOL BY SUBLIMATION TECHNIQUE

Product list Magnesium, Calcium and further mineral compounds

SUCRALOSE. White to off-white, practically odourless crystalline powder

MEDICATION GUIDE JUXTAPID (JUKS-tuh-pid) (lomitapide) capsules

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Review Article

5/13/2010. Excipient Fest Porto Rico May PDF created with pdffactory Pro trial version Location

Particle size measurement of lactose for dry powder inhalers

Tamsulosin Hydrochloride Capsules

International Journal of Pharmaceutical Research & Analysis

Continuous Granulation and Drying

Keltan 6251A A Versatile Sponge Grade

In this column installment, we present results of tablet. Raman Microscopy for Detecting Counterfeit Drugs A Study of the Tablets Versus the Packaging

Drospirenone and Ethinyl Estradiol Tablets. Type of Posting. Revision Bulletin Posting Date. 31 July 2015 Official Date

Workshop A Design Space (DS)

Carolina s Solution Preparation Manual

Multivariate Chemometric and Statistic Software Role in Process Analytical Technology

Fast Dissolving Tablets of Aloe Vera Gel

Saint Gobain Gyproc India Ltd. (Formerly India Gypsum Ltd.)

Taking Apart the Pieces

UNIVERSITY OF PARMA INTERDEPARTMENTAL CENTRE FOR INNOVATION IN HEALTH PRODUCTS, BIOPHARMANET-TEC

Physical & Chemical Properties. Properties

This document was presented at the Denver X-ray Conference (DXC) on Applications of X-ray Analysis.

Transcription:

PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-95 Page 1 of 5 Utility of Polyplasdone as a Tablet Binder Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland Specialty Ingredients, Wilmington, Delaware 1988, USA Introduction Superdisintegrants can play a major role in tablet formulations. Their main function is to greatly increase the drug dissolution rate of solid dosage forms. The goal of this study was to evaluate the binding capacity of several superdisintegrants, when used as a binder for roller compaction in immediate-release (IR) and orally disintegrating tablet (ODT) formulations, using ranitidine HCl as a model drug. Superdisintegrants evaluated in this study were as follows: Polyplasdone Competitive Methods Pure Polymer Characterization and Compaction Comparison of Superdisintegrants. For each superdisintegrant, the Carr loose and packed bulk densities were measured using the Hosokawa powder flow tester. The compressibility was determined by the following formula: Compressibility (%) = [1 (Packed Density Loose Density)] / Packed Density Flowability of each superdisintegrant was determined by using the Carr Cohesion measurement method. Because the physical and chemical properties of the Ultra and XL grades of Polyplasdone are the same (the only difference being in the level of impurities) these grades are used interchangeably in this study. The competitive CL and CL-F grades of vary only in particle size and are also used interchangeably. Preparation of 28 mg Pure Superdisintegrant Tablets. Each superdisintegrant was blended with stearic acid (Table 1) and compressed at four different compression forces (5, 1, 15, and 2 kn) using 3/8 flat faced, beveled edge tooling on a Manesty Betapress. However, both croscarmellose sodium and sodium starch glycolate needed higher compression forces to maintain tablet hardness. Table 1. Pure superdisintegrant tablet formulation Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.8 Total 1 28 Preparation of 56 mg IR Ranitidine HCl Tablets. The first three ingredients in Table 2 were passed through an 18 mesh screen and blended for 1 minutes. All statements, information, and data presented herein are believed to be accurate and reliable, but are not to be taken as a guarantee, an express warranty, or an implied warranty of merchantability or fitness for a particular purpose, or representation, express or implied, for which Ashland assumes legal responsibility. Registered trademark, Ashland or its subsidiaries, registered in various countries. Trademark, Ashland or its subsidiaries, registered in various countries. *Trademark owned by a third party. 214, Ashland. Rev. 2-214

Page 2 of 5 Table 2. IR Ranitidine HCl tablet formulation The blend was compacted into ribbons by a roller compactor with the following parameters: Roller speed: 6. RPM Roll gap:.8 mm Roll force: 2.2 kn/cm The ribbons were milled in the FitzMill with a.65" screen, knives forward and medium speed. The milled ranitidine granulation was passed through an 18 mesh screen. Magnesium stearate was passed through a 35 mesh screen, added to the screened granulation, and blended for 3 minutes. The final blend was compressed on a Manesty Betapress using 7/16 FFBE tooling, to a tablet weight of 56 mg. Tablet hardness, thickness, friability, and disintegration time were tested. Dissolution of IR Ranitidine HCl Tablets. Dissolution (n = 6) was conducted in 9 ml deionized (DI) water at 37 C using the USP apparatus II at 5 rpm paddle speed (Distek Dissolution System, Model 51). The amount of ranitidine dissolved was monitored using a UV spectrophotometer (Agilent 8453) at 22 nm. Samples were taken at 7.5, 15, 3, and 45 minutes. Results and Discussion Ingredients Tablet formulation (%w/w) Intragranular Tablet weight (mg) Ranitidine HCl 3 168 Lactose 49 274.4 Superdisintegrant 2 112 Extragranular Magesium stearate 1 5.6 Total 1 56 Pure Polymer Characterization and Compaction Comparison of Superdisintegrants, Figure 1 shows that sodium starch glycolate has the highest flowability index but lowest compressibility, due to its spherical morphology. Both croscarmellose sodium and have good compressibility but lower flowability due to their fibrous structures. Polyplasdone XL shows good compressibility and flowability values. Also, in the pure polymer compaction study, Polyplasdone XL produced tablets with the highest breaking force (Figure 2). On the basis of this information we concluded that Polyplasdone can be used as a binder for ranitidine HCl tablets.

Hardness (kp) Page 3 of 5 1 9 8 7 6 5 4 3 2 1 Compressibility Flowability Index Figure 1. Compressibility and flowability of superdisintegrants 35 3 25 2 15 Polyplasdone XL Competitive equivalent CL 1 5 5 1 15 2 25 3 Compression Force (kn) Figure 2. Pure polymer compaction comparison of superdisintegrants IR Ranitidine HCl Tablets. Microcrystalline cellulose (MCC) is often used as a primary binder for roller compaction. Figure 3 shows the tablets made with MCC or yielded harder tablets than tablets made with other polymers. However, the tablets made with Polyplasdone Ultra had the shortest disintegration times, and somewhat faster drug release than tablets made with other polymers (Figure 4 and 5).

Disintegration Time (sec) Hardness (kp) Page 4 of 5 16 14 12 1 8 No disintegrant, microcrystalline cellulose as binder Polyplasdone Ultra Competitive equivalent 6 4 2 1 15 2 Compression Forces (kn) Figure 3. Effect of compression force on hardness of IR ranitidine HCl tablets 5 45 4 35 3 Polyplasdone Ultra Competitive equivalent Microcrystalline cellulose 25 2 15 1 5 1 15 2 Compression Force (kn) Figure 4. Disintegration time of IR ranitidine HCl tablets

Percent ranitidine released Page 5 of 5 1 9 8 7 6 5 4 3 Polyplasdone Ultra Competitive equivalent 2 1 5 1 15 2 25 3 Time (min) Figure 5. Dissolution of IR ranitidine HCl tablets in DI water Conclusions The good flowability, compressibility and high breaking force of the pure Polyplasdone XL or Ultra s tablets demonstrate the binding ability of Polyplasdone XL or Ultra. Also, the hardness, disintegration and dissolution results of IR ranitidine HCl tablets show that Polyplasdone s are not only good binders for dry granulation, but also excellent superdisintegrants for any solid dosage form.